...
首页> 外文期刊>Journal of Neuroscience Research >Downregulation of miR-181b in mouse brain following ischemic stroke induces neuroprotection against ischemic injury through targeting heat shock protein A5 and ubiquitin carboxyl-terminal hydrolase isozyme L1
【24h】

Downregulation of miR-181b in mouse brain following ischemic stroke induces neuroprotection against ischemic injury through targeting heat shock protein A5 and ubiquitin carboxyl-terminal hydrolase isozyme L1

机译:缺血性中风后小鼠脑中miR-181b的下调通过靶向热休克蛋白A5和遍在蛋白羧基末端水解酶同工酶L1诱导神经保护免受缺血性损伤

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Understanding the molecular mechanism of cerebral hypoxic preconditioning (HPC)-induced endogenous neuroprotection may provide potential therapeutic targets for ischemic stroke. By using bioinformatics analysis, we found that miR-181b, one of 19 differentially expressed miRNAs, may target aconitate hydratase (ACO2), heat shock protein A5 (HSPA5), and ubiquitin carboxyl-terminal hydrolase isozyme L1 (UCHL1) among 26 changed protein kinase C isoform-specific interacting proteins in HPC mouse brain. In this study, the role of miR-181b in oxygen-glucose deprivation (OGD)-induced N2A cell ischemic injury in vitro and mouse middle cerebral artery occlusion (MCAO)-induced cerebral ischemic injury in vivo, and its regulation of ACO2, HSPA5, and UCHL1 were further determined. We found that miR-181b expression levels significantly decreased in mouse brain following MCAO and in OGD-treated N2A cells. Up- and downregulation of miR-181b by transfection of pre- or anti-miR-181b could negatively regulate HSPA5 and UCHL1 (but not ACO2) protein levels as well as N2A cell death and programmed cell death in OGD-treated N2A cells. By using a T7 promoter-driven control dual luciferase assay, we confirmed that miR-181b could bind to the 3′-untranslated rergions of HSPA5 and UCHL1 mRNAs and repress their translations. miR-181b antagomir reduced caspase-3 cleavage and neural cell loss in cerebral ischemic cortex and improved neurological deficit of mice after MCAO. In addition, HSPA5 and UCHL1 short interfering RNAs (siRNAs) blocked anti-miR-181b-mediated neuroprotection against OGD-induced N2A cell injury in vitro. These results suggest that the downregulated miR-181b induces neuroprotection against ischemic injury through negatively regulating HSPA5 and UCHL1 protein levels, providing a potential therapeutic target for ischemic stroke.
机译:了解脑缺氧预处理(HPC)诱导的内源性神经保护的分子机制可能为缺血性中风提供潜在的治疗目标。通过生物信息学分析,我们发现19种差异表达的miRNA之一miR-181b可能靶向乌头酸水合酶(ACO2),热休克蛋白A5(HSPA5)和泛素羧基末端水解酶同工酶L1(UCHL1)。 HPC小鼠大脑中的激酶C异构体特异性相互作用蛋白。在这项研究中,miR-181b在体内氧葡萄糖剥夺(OGD)诱导的N2A细胞缺血损伤和体内小鼠中脑动脉闭塞(MCAO)诱导的脑缺血损伤中的作用及其对ACO2,HSPA5的调节和UCHL1进一步确定。我们发现,在MCAO之后和OGD处理的N2A细胞中,小鼠大脑中miR-181b表达水平显着降低。通过转染pre-或抗miR-181b来上调和下调miR-181b可能会对OSPA处理的N2A细胞中的HSPA5和UCHL1(但不是ACO2)蛋白水平以及N2A细胞死亡和程序性细胞死亡产生负调控。通过使用T7启动子驱动的对照双荧光素酶测定,我们证实miR-181b可以与HSPA5和UCHL1 mRNA的3'-非翻译区域结合并抑制其翻译。 miR-181b antagomir减少了MCAO后小鼠脑缺血皮质中caspase-3的裂解和神经细胞的丢失,并改善了小鼠的神经功能缺损。此外,HSPA5和UCHL1短干扰RNA(siRNA)在体外阻断了抗miR-181b介导的针对OGD诱导的N2A细胞损伤的神经保护。这些结果表明,下调的miR-181b通过负调节HSPA5和UCHL1蛋白水平诱导针对缺血性损伤的神经保护,为缺血性中风提供了潜在的治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号